Study details
Enrolling now
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
National Cancer Institute (NCI)
NCT IDNCT05691517ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Ages
18+
Locations
1 site in MD
About this study
This Phase 1 study is focused on people with advanced malignant solid neoplasm.
Based on ClinicalTrials.gov records.
PhasePhase 1
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low15%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Procedures
biopsy, diagnostic, imaging